The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Drynol 6 mg/mL eye drops, solution

Menarini International Operations Luxembourg S.A.PA0865/018/005

Main Information

Trade NameDrynol 6 mg/mL eye drops, solution
Active SubstancesBilastine
Dosage FormEye drops, solution
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberPA0865/018/005

Group Information

ATC CodeS01GX13 ophthalmologicals; decongestant and antiallergics


License statusAuthorised
Licence Issued22/07/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back